129357-91-1 Usage
Uses
Used in Pharmaceutical Industry:
((2Z,4aS,8S,8aS)-2-[1-(5-oxohexyl)octylidene]octahydro-2H-chromen-8-ylsulfanyl)acetic acid can be utilized as a pharmaceutical agent due to its potential interactions with biological molecules. Its diverse functional groups may allow it to modulate enzyme activity, bind to protein targets, or affect cell membrane properties, making it a candidate for the development of new drugs or drug delivery systems.
Used in Chemical Research:
In the field of chemical research, ((2Z,4aS,8S,8aS)-2-[1-(5-oxohexyl)octylidene]octahydro-2H-chromen-8-ylsulfanyl)acetic acid serves as a subject for studying its chemical reactivity and potential reactions with other compounds. Understanding its reactivity could lead to the discovery of new chemical processes or the synthesis of novel molecules with unique properties.
Used in Material Science:
((2Z,4aS,8S,8aS)-2-[1-(5-oxohexyl)octylidene]octahydro-2H-chromen-8-ylsulfanyl)acetic acid may also find applications in material science, where its structural features and functional groups could be exploited to create new materials with specific properties. These materials could have uses in various industries, such as in the development of sensors, coatings, or advanced materials with tailored characteristics.
Check Digit Verification of cas no
The CAS Registry Mumber 129357-91-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,9,3,5 and 7 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 129357-91:
(8*1)+(7*2)+(6*9)+(5*3)+(4*5)+(3*7)+(2*9)+(1*1)=151
151 % 10 = 1
So 129357-91-1 is a valid CAS Registry Number.
129357-91-1Relevant academic research and scientific papers
CONFORMATIONALLY RESTRICTED LEUKOTRIENE ANTAGONISTS. STEREOSELECTIVE SYNTHESIS OF SOME LEUKOTRIENE D4 ANALOGS
Sabol, Jeffrey S.,Weintraub, Philip M.,Gieske, Thomas H.,Cregge, Robert J.
, p. 4155 - 4160 (2007/10/02)
The stereocontrolled synthesis of conformationally restricted LTD4 analogs 2a, b is described.Epoxidation of enone 4 affords a 2.4:1 mixture of trans-epoxide 5 and cis-epoxide 9.Stereocontrolled elaboration of each epoxide to final product invo
